{"id":89542,"date":"2026-05-22T11:44:49","date_gmt":"2026-05-22T11:44:49","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/89542\/"},"modified":"2026-05-22T11:44:49","modified_gmt":"2026-05-22T11:44:49","slug":"european-medicines-regulator-recommends-approval-for-novos-wegovy-pill","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/89542\/","title":{"rendered":"European medicines regulator recommends approval for Novo&#8217;s Wegovy pill"},"content":{"rendered":"<p><a data-ylk=\"elm:icon;slk:Reuters;\" href=\"https:\/\/www.reuters.com\/\" target=\"_blank\" rel=\"nofollow noopener\"><img alt=\"Reuters\" loading=\"lazy\" width=\"171\" height=\"40\" decoding=\"async\" data-nimg=\"1\" class=\"pr-2.5 max-w-[150px] max-h-[40px] min-[601px]:max-w-[115px]\" style=\"color:transparent;max-width:auto;max-height:100%\" src=\"https:\/\/www.europesays.com\/dk\/wp-content\/uploads\/2026\/05\/https:\/\/s.yimg.com\/os\/creatr-uploaded-images\/2020-11\/62e21440-2fbd-11eb-95ff-5673fa3d2f9f.jpeg\"\/><\/a>Fri, May 22, 2026 at 10:51 AM UTC<img alt=\"\" loading=\"lazy\" width=\"976\" height=\"650\" decoding=\"async\" data-nimg=\"1\" class=\"standard-img w-full w-full h-auto\" style=\"color:transparent\" src=\"https:\/\/www.europesays.com\/dk\/wp-content\/uploads\/2026\/05\/https:\/\/media.zenfs.com\/en\/reuters.com\/fc9f224cdcb05d3894c17a85ee72cc12.jpeg\"\/><\/p>\n<p>FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. REUTERS\/Tom Little\/File Photo<\/p>\n<p>May 22 (Reuters) &#8211; The European Medicines Agency recommended approval \u200cfor Novo Nordisk&#8217;s weight-loss pill \u200cWegovy, the regulator said on Friday, \u200bclearing its path to become the first oral weight-loss drug in Europe, ahead of \u200cU.S. rival \u2060Eli Lilly.<\/p>\n<p>The recommendation comes as competition between Novo \u2060and Lilly intensifies, with both companies seeking to grow their \u200bshare of \u200bthe \u200bbooming obesity drug \u200cmarket\u2014expected by analysts to reach $150 billion annually in the next decade\u2014by expanding into oral treatments.<\/p>\n<p>Novo launched the pill in the \u200cUnited States earlier \u200bthis year after \u200bwinning \u200bFDA approval, giving it \u200can early start. \u200bLilly&#8217;s weight-loss \u200bpill, Foundayo, was launched in April following its U.S. \u200bapproval.<\/p>\n<p>(Reporting \u200cby Kunal Das and Puyaan \u200bSingh in Bengaluru; Editing \u200bby Tasim Zahid)<\/p>\n","protected":false},"excerpt":{"rendered":"Fri, May 22, 2026 at 10:51 AM UTC FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is&hellip;\n","protected":false},"author":2,"featured_media":89543,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[276,32071,7734,272,18580,3388],"class_list":["post-89542","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-eli-lilly","tag-european-medicines-agency","tag-fda-approval","tag-novo-nordisk","tag-oral-treatments","tag-weight-loss-drug"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@dk\/116618063066656943","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/89542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=89542"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/89542\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/89543"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=89542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=89542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=89542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}